Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangkui Capsule for Diabetic Kidney Disease
NCT03016832Phase 1Unknown
- Sponsor
- Jiangsu Famous Medical Technology
- Start
- Jan 2017
- Primary completion
- May 2018
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of huang kui capsule in diabetic kidney disease (DKD) (3 arms), sponsored by Jiangsu Famous Medical Technology. Primary endpoint: Albumin/Creatinine Ratio at 24 weeks. Status: unknown.
02
Drugs
huang kui capsule
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT03016832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03016832.